CRNX logo

Crinetics Pharmaceuticals (CRNX) Shareholders Equity

Annual Shareholders Equity

$539.11 M
+$222.78 M+70.43%

31 December 2023

CRNX Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$832.98 M
+$2.22 M+0.27%

30 September 2024

CRNX Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRNX Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+70.4%+52.1%
3 y3 years+219.2%+330.3%
5 y5 years+236.5%+543.1%

CRNX Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+219.2%-4.8%+330.3%
5 y5 yearsat high+360.2%-4.8%+668.2%
alltimeall timeat high+3688.8%-4.8%+3408.5%

Crinetics Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$832.98 M(+0.3%)
June 2024
-
$830.76 M(-5.0%)
Mar 2024
-
$874.93 M(+62.3%)
Dec 2023
$539.11 M(+70.4%)
$539.11 M(-1.6%)
Sept 2023
-
$547.75 M(+115.6%)
June 2023
-
$254.12 M(-9.4%)
Mar 2023
-
$280.33 M(-11.4%)
Dec 2022
$316.33 M(-4.7%)
$316.33 M(-10.0%)
Sept 2022
-
$351.37 M(-9.0%)
June 2022
-
$386.17 M(+27.4%)
Mar 2022
-
$303.04 M(-8.7%)
Dec 2021
$331.94 M
$331.94 M(+71.5%)
Sept 2021
-
$193.59 M(-3.9%)
June 2021
-
$201.44 M(+34.8%)
DateAnnualQuarterly
Mar 2021
-
$149.48 M(-11.5%)
Dec 2020
$168.92 M(+44.2%)
$168.92 M(-9.8%)
Sept 2020
-
$187.22 M(-7.7%)
June 2020
-
$202.77 M(+87.0%)
Mar 2020
-
$108.44 M(-7.4%)
Dec 2019
$117.14 M(-26.9%)
$117.14 M(-9.6%)
Sept 2019
-
$129.52 M(-8.9%)
June 2019
-
$142.10 M(-6.8%)
Mar 2019
-
$152.39 M(-4.9%)
Dec 2018
$160.22 M(-1166.6%)
$160.22 M(-4.4%)
Sept 2018
-
$167.52 M(-765.4%)
June 2018
-
-$25.18 M(+26.0%)
Mar 2018
-
-$19.98 M(+33.0%)
Dec 2017
-$15.02 M(+142.1%)
-$15.02 M
Dec 2016
-$6.20 M
-

FAQ

  • What is Crinetics Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Crinetics Pharmaceuticals?
  • What is Crinetics Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Crinetics Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Crinetics Pharmaceuticals?
  • What is Crinetics Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Crinetics Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of CRNX is $539.11 M

What is the all time high annual shareholders equity for Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals all-time high annual stockholders equity is $539.11 M

What is Crinetics Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, CRNX annual stockholders equity has changed by +$222.78 M (+70.43%)

What is Crinetics Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of CRNX is $832.98 M

What is the all time high quarterly shareholders equity for Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals all-time high quarterly stockholders equity is $874.93 M

What is Crinetics Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, CRNX quarterly stockholders equity has changed by +$285.23 M (+52.07%)